Northwest Biotherapeutics (NWBO) EPS (Basic) (2010 - 2026)
Northwest Biotherapeutics (NWBO) posted quarterly EPS (Basic) of -$0.0 for Q1 2026, up 99.99% year-over-year from -$0.0 in Q1 2025, and down 349.8% quarter-over-quarter from $0.0 in Q4 2025.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) EPS (Basic) (2010 - 2026) Analysis & Trends
Northwest Biotherapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.0 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 99.99% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$0.03 (up 99.95% YoY), while the FY2025 annual figure was -$0.04, up 99.94% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.0, down from $0.0 in the prior quarter.
- The five-year high for EPS (Basic) was $0.0 in Q4 2025, with the low at -$31.56 in Q3 2022.
- The 5-year median for EPS (Basic) is -$15.08 (2024), against an average of -$16.16.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) tumbled 726.85% in 2022, then soared 100.0% in 2025.
- Northwest Biotherapeutics' EPS (Basic) stood at -$27.86 in 2022, then surged by 54.07% to -$12.79 in 2023, then plunged by 79.31% to -$22.94 in 2024, then surged by 100.0% to $0.0 in 2025, then plunged by 349.8% to -$0.0 in 2026.
- Business Quant data shows NWBO's EPS (Basic) at -$0.0 in Q1 2026, $0.0 in Q4 2025, and -$18.22 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Northwest Biotherapeutics | 278.23 Mn | 277.63 Mn | - | -0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | -18.22 |
| Jun 30, 2025 | -11.08 |
| Mar 31, 2025 | -14.42 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -15.50 |
| Jun 30, 2024 | -15.08 |
| Mar 31, 2024 | -15.89 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -21.19 |
| Jun 30, 2023 | -13.50 |
| Mar 31, 2023 | -10.28 |
| Dec 31, 2022 | -0.03 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.03 |
| Mar 31, 2022 | -0.02 |
| Dec 31, 2021 | 0.20 |
| Sep 30, 2021 | 0.01 |